Why Stress? Reevaluating the Use of Stress Ulcer Prophylaxis in Select At-Risk Populations

<p>Jo Ann Leal, Pharm.D., describes the epidemiology of stress ulcers and stress ulcer prophylaxis in select critically ill patients, evaluates the literature that examines the incidence of gastrointestinal bleeding in patients receiving corticosteroids and the outcomes of stress ulcer prophylaxis in patients on dual antiplatelet therapy and analyzes the literature regarding the outcomes of stress ulcer prophylaxis in neurological conditions. </p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>